 Intracarotid chemotherapy etoposide cisplatin malignant brain tumors Chemotherapy tumors central nervous system limited efficacy restricted blood-brain barrier permeability advantage regional intra-arterial administration anticancer drugs increased uptake first passage drugs tumor capillaries patients high-grade astrocytomas HGA patients metastatic brain tumors MBT intracarotid/intravertebral infusion etoposide cisplatin patients HGA incomplete resection additional patients complete resection tumor Median survival time group responders nonresponders months patients MBT complete response CR partial response PR median survival time months Intra-arterial chemotherapy IAC effective acceptable toxicities Accrual additional patients final conclusion